Antibody Tests May Answer Public Health Questions
Andrew Azman, PhD, assistant scientist, department of epidemiology, Johns Hopkins University Bloomberg School of Public Health.
Michael Mina, MD, PhD, assistant professor of epidemiology, Harvard T.H. Chan School of Public Health.
Eric Blank, DrPH, chief program officer, Association of Public Health Laboratories.
CDC.gov: “Interim Guidelines for COVID-19 Antibody Testing.”
FDA: “EUA Authorized Serology Test Performance,” “Insight into FDA’s Revised Policy on Antibody Tests: Prioritizing Access and Accuracy,” “Coronavirus (COVID-19) Update: Daily Roundup May 4, 2020.”
Centre for the Mathematical Modelling of Infectious Diseases and the London School of Hygiene & Tropical Medicine: “Critical immunity thresholds for measles elimination.”
House Committee on Oversight and Reform: “Subcommittee Investigation Leads to FDA Increasing Oversight and Accuracy on Serology Testing.”
Quest Diagnostics: “Quest Diagnostics Media Statement about COVID-19 Testing.”
LabCorp: “LabCorp’s COVID-19 IgG Antibody Test is Available.”
Association of Public Health Laboratories: “Antibody Testing Is Important in COVID-19 Response, But More Data Is Needed to Expand Its Role.”
Science Immunology: “Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.”
Clinicaltrials.gov: “Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms.”
Science:
“DNA vaccine protection against SARS-CoV-2 in rhesus macaques.”
The
Lancet:
“Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.”
NBCnews.com: “Can herd immunity help stop the coronavirus? Experts warn it’s not that easy.”
